Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Find clinical trials that match your diagnosis, stage and treatment history.
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Cancer Research Institute collaboration with the Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb, and Apexigen will test CD40 antibody APX005M, nivolumab, and chemotherapy in pancreatic cancer patients.
First-of-its kind campaign to fund promising immunotherapy research in Israel, a global leader in cancer research
Fight Colorectal Cancer and the Cancer Research Institute announce the recipient of their jointly-funded $400k grant to support immunotherapy research in metastatic colorectal cancer.
CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system
The Focused Ultrasound Foundation (FUSF) and the Cancer Research Institute (CRI) are establishing a partnership with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy treatments.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in 2018!
Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to fit individual patients